Evidence map›Paper›PMID 37461608›Full record

ArticleResearch square2023

Cancer Prevalence Across Vertebrates.

Zachary T Compton, Valerie Harris, Walker Mellon, Shawn Rupp, Diego Mallo, Stefania E Kapsetaki, Mallory Wilmot, Ryan Kennington, Kathleen Noble, Cristina Baciu and 22 more

Abstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Zachary T ComptonArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Valerie HarrisArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Walker MellonArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Shawn RuppArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Diego MalloArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.ORCID 0000-0002-9046-8859
Stefania E KapsetakiArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Mallory WilmotDepartment of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Ryan KenningtonDepartment of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Kathleen NobleDepartment of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Cristina BaciuArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Lucia RamirezGenomic Sciences Graduate Program, North Carolina State University, Raleigh, NC.
Ashley PerazaArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Brian MartinsArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Sushil SudhakarArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Selin AksoyArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.
Gabriella FurukawaDepartment of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Orsolya VinczeInstitute of Aquatic Ecology, Centre for Ecological Research, 4026 Debrecen, Hungary.
Mathieu GiraudeauLIENSs, UMR 7266 CNRS-La Rochelle Université, La Rochelle, France.
Elizabeth G DukeNorth Carolina State College of Veterinary Medicine, Raleigh, NC.
Simon SpiroWildlife Health Services, Zoological Society of London, London, UK.ORCID 0000-0002-9621-2192
Edmund FlachWildlife Health Services, Zoological Society of London, London, UK.ORCID 0000-0003-4842-9589
Hannah DavidsonNorth Carolina State College of Veterinary Medicine, Raleigh, NC.
Ashley ZehnderExotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, NC.
Trevor A GrahamCentre for Evolution and Cancer, Institute of Cancer Research, London, UK.ORCID 0000-0001-9582-1597
Brigid TroanNorth Carolina State College of Veterinary Medicine, Raleigh, NC.
Tara M HarrisonNorth Carolina State College of Veterinary Medicine, Raleigh, NC.ORCID 0000-0002-2072-5936
Marc TollisSchool of Informatics, Computing and Cyber Systems, Northern Arizona University, Flagstaff, AZ.
Joshua D SchiffmanArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.ORCID 0000-0002-6968-7694
Athena AktipisArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.ORCID 0000-0002-7128-670X
Lisa M AbegglenArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.ORCID 0000-0003-3607-3001
Carlo C MaleyArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.ORCID 0000-0002-0745-7076
Amy M BoddyArizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ.

Funding

PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
Molecular, Cellular and Tissue Characterization UnitU2CCA233254 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY, MALEY, CARLO · 2018 to 2023
$11.4M
The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
T32 Cancer Prevention and Control Training Program Addressing Health DisparitiesT32CA272303 · NCI · UNIVERSITY OF ARIZONA · PI Terry A Badger, Gloria D. Coronado · 2023 to 2026
$1.1M
NCI NIH HHS P01 CA091955NCI NIH HHS R01 CA140657NCI NIH HHS T32 CA272303NCI NIH HHS U2C CA233254NCI NIH HHS U54 CA217376
6 · The paper itself

Abstract

Cancer is pervasive across multicellular species, but what explains differences in cancer prevalence across species? Using 16,049 necropsy records for 292 species spanning three clades (amphibians, sauropsids and mammals) we found that neoplasia and malignancy prevalence increases with adult weight (contrary to Peto's Paradox) and somatic mutation rate, but decreases with gestation time. Evolution of cancer susceptibility appears to have undergone sudden shifts followed by stabilizing selection. Outliers for neoplasia prevalence include the common porpoise (<1.3%), the Rodrigues fruit bat (<1.6%) the black-footed penguin (<0.4%), ferrets (63%) and opossums (35%). Discovering why some species have particularly high or low levels of cancer may lead to a better understanding of cancer syndromes and novel strategies for the management and prevention of cancer.

Identifiers

PMID37461608
PMCPMC10350200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.